| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| FXYD7 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH305819 | 10 ug | ORIGENE TECHNOLOGIES |
| 5'-nucleotidase, cytosolic IB (NT5C1B), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424317 | 100 ug | ORIGENE TECHNOLOGIES |
| 5'-nucleotidase, cytosolic IB (NT5C1B), transcript variant 2 from ORIGENE TECHNOLOGIES | LY409657 | 100 ug | ORIGENE TECHNOLOGIES |
| 5'-nucleotidase, cytosolic IB (NT5C1B), transcript variant 4 from ORIGENE TECHNOLOGIES | LY434341 | 100 ug | ORIGENE TECHNOLOGIES |
| 5'-nucleotidase, cytosolic III-like (NT5C3L) from ORIGENE TECHNOLOGIES | LY409391 | 100 ug | ORIGENE TECHNOLOGIES |
| 5'-nucleotidase, cytosolic III (NT5C3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424319 | 100 ug | ORIGENE TECHNOLOGIES |
| 5'-nucleotidase, cytosolic III (NT5C3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY425069 | 100 ug | ORIGENE TECHNOLOGIES |
| 5'-nucleotidase, cytosolic III (NT5C3), transcript variant 3 from ORIGENE TECHNOLOGIES | LY413931 | 100 ug | ORIGENE TECHNOLOGIES |
| 5'-nucleotidase, cytosolic III (NT5C3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY424318 | 100 ug | ORIGENE TECHNOLOGIES |
| 5'-nucleotidase, cytosolic II (NT5C2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415891 | 100 ug | ORIGENE TECHNOLOGIES |
| 5'-nucleotidase, cytosolic II (NT5C2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY427403 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 15 open reading frame 57 (C15orf57), transcript variant 2 from ORIGENE TECHNOLOGIES | LY409459 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 16 open reading frame 13 (C16orf13), transcript variant 1 from ORIGENE TECHNOLOGIES | LY410160 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 16 open reading frame 13 (C16orf13), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429803 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 16 open reading frame 13 (C16orf13), transcript variant 3 from ORIGENE TECHNOLOGIES | LY421703 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 16 open reading frame 35 (C16orf35), transcript variant 1 from ORIGENE TECHNOLOGIES | LY421399 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 16 open reading frame 35 (C16orf35), transcript variant 2 from ORIGENE TECHNOLOGIES | LY422054 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 16 open reading frame 45 (C16orf45), transcript variant 1 from ORIGENE TECHNOLOGIES | LY409626 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 16 open reading frame 45 (C16orf45), transcript variant 2 from ORIGENE TECHNOLOGIES | LY428115 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 16 open reading frame 46 (C16orf46), transcript variant 2 from ORIGENE TECHNOLOGIES | LY407588 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 16 open reading frame 57 (C16orf57), transcript variant 2 from ORIGENE TECHNOLOGIES | LY434095 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 16 open reading frame 73 (C16orf73), transcript variant 1 from ORIGENE TECHNOLOGIES | LY431419 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 16 open reading frame 73 (C16orf73), transcript variant 2 from ORIGENE TECHNOLOGIES | LY432247 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 16 open reading frame 89 (C16orf89), transcript variant 1 from ORIGENE TECHNOLOGIES | LY407519 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 16 open reading frame 92 (C16orf92), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426298 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 16 open reading frame 95 (C16orf95), transcript variant 2 from ORIGENE TECHNOLOGIES | LY434000 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 101 (C17orf101), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406203 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 45 (C17orf45), transcript variant 1 from ORIGENE TECHNOLOGIES | LY407600 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 109 (C17orf109), transcript variant 1 from ORIGENE TECHNOLOGIES | LY431054 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 49 (C17orf49), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406297 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 49 (C17orf49), transcript variant 3 from ORIGENE TECHNOLOGIES | LY428281 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 53 (C17orf53), transcript variant 2 from ORIGENE TECHNOLOGIES | LY433389 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 53 (C17orf53), transcript variant 1 from ORIGENE TECHNOLOGIES | LY411409 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 62 (C17orf62), transcript variant 1 from ORIGENE TECHNOLOGIES | LY420251 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 58 (C17orf58), transcript variant 1 from ORIGENE TECHNOLOGIES | LY405743 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 62 (C17orf62), transcript variant 2 from ORIGENE TECHNOLOGIES | LY422350 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 62 (C17orf62), transcript variant 3 from ORIGENE TECHNOLOGIES | LY420252 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 63 (C17orf63), transcript variant 1 from ORIGENE TECHNOLOGIES | LY425871 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 63 (C17orf63), transcript variant 1 from ORIGENE TECHNOLOGIES | LY421447 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 63 (C17orf63), transcript variant 2 from ORIGENE TECHNOLOGIES | LY413227 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 70 (C17orf70), transcript variant 1 from ORIGENE TECHNOLOGIES | LY410860 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 72 (C17orf72), transcript variant 2 from ORIGENE TECHNOLOGIES | LY431150 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 76 (C17orf76), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426437 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 76 (C17orf76), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404000 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 80 (C17orf80), transcript variant 1 from ORIGENE TECHNOLOGIES | LY413426 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 81 (C17orf81), transcript variant 1 from ORIGENE TECHNOLOGIES | LY414599 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 81 (C17orf81), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429459 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 81 (C17orf81), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404350 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 81 (C17orf81), transcript variant 2 from ORIGENE TECHNOLOGIES | LY430922 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 17 open reading frame 81 (C17orf81), transcript variant 3 from ORIGENE TECHNOLOGIES | LY404351 | 100 ug | ORIGENE TECHNOLOGIES |